DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies von Schultz, Kris Ann P, Williams, Gretchen M, Kamihara, Junne, Stewart, Douglas R, Harris, Anne K, Bauer, Andrew J, Turner, Joyce, Shah, Rachana, Schneider, Katherine, Schneider, Kami Wolfe, Carr, Ann Garrity, Harney, Laura A, Baldinger, Shari, Frazier, A Lindsay, Orbach, Daniel, Schneider, Dominik T, Malkin, David, Dehner, Louis P, Messinger, Yoav H, Hill, D Ashley

Volltext

Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study von Khan, Nicholas E., Bauer, Andrew J., Schultz, Kris Ann P., Doros, Leslie, Decastro, Rosamma M., Ling, Alexander, Lodish, Maya B., Harney, Laura A., Kase, Ron G., Carr, Ann G., Rossi, Christopher T., Field, Amanda, Harris, Anne K., Williams, Gretchen M., Dehner, Louis P., Messinger, Yoav H., Hill, D. Ashley, Stewart, Douglas R.

Volltext

Liver fibrosis among infants with t(1;22)(p13;q13) acute megakaryoblastic leukemia: a case report and literature review von Arad-Cohen, Nira, Attias, Ori, Zohar, Yaniv, Messinger, Yoav H

Volltext

Bortezomib‐based four‐drug induction does induce a response in advanced relapsed ALL but cure remains elusive von Messinger, Yoav H., Bostrom, Bruce C.

Volltext

Elimination of Antibodies to Recombinant Enzyme in Pompe's Disease von Kishnani, Priya S, Rosenberg, Amy S, Mendelsohn, Nancy J, Messinger, Yoav H

Volltext

Impact of the COVID-19 pandemic on utilization and cost for care of pediatric and young adult ALL von Hoover, Alex, Watson, Dave, Reimche, Paige, Tanner, Lynn, Gilchrist, Laura, Finch, Mike, Messinger, Yoav H, Turcotte, Lucie M

Volltext

Bortezomib Comes to the Rescue: Comment on the Article by Nachmias et al. Entitled “A Bortezomib-Based Protocol Induces a High Rate of CR with Minor Toxicity in Adult Patients with... von Messinger, Yoav H. , Bostrom, Bruce C.

Volltext

STXBP2-R190C Variant in a Patient With Neonatal Hemophagocytic Lymphohistiocytosis (HLH) and G6PD Deficiency Reveals a Critical Role of STXBP2 Domain 2 on Granule Exocytosis von Benavides, Nathalia, Spessott, Waldo A, Sanmillan, Maria L, Vargas, Marcelo, Livingston, Mylynda S, Erickson, Nissa, Pozos, Tamara C, McCormick, Margaret E, Scharrig, Emilia, Messinger, Yoav H, Giraudo, Claudio G

Volltext

Healthcare cost and utilization for chimeric antigen receptor (CAR) T‐cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims databas... von Hoover, Alex, Reimche, Paige, Watson, Dave, Tanner, Lynn, Gilchrist, Laura, Finch, Mike, Messinger, Yoav H., Turcotte, Lucie M.

Volltext

Pleuropulmonary blastoma: A report on 350 central pathology–confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry von Messinger, Yoav H, Stewart, Douglas R, Priest, John R, Williams, Gretchen M, Harris, Anne K, Schultz, Kris Ann P, Yang, Jiandong, Doros, Leslie, Rosenberg, Philip S, Hill, D. Ashley, Dehner, Louis P

Volltext

Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in DICER1 von Stewart, Douglas R, Best, Ana F, Williams, Gretchen M, Harney, Laura A, Carr, Ann G, Harris, Anne K, Kratz, Christian P, Dehner, Louis P, Messinger, Yoav H, Rosenberg, Philip S, Hill, D Ashley, Schultz, Kris Ann P

Volltext

Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study von Messinger, Yoav H., Gaynon, Paul S., Sposto, Richard, van der Giessen, Jeannette, Eckroth, Elena, Malvar, Jemily, Bostrom, Bruce C.

Volltext

Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma von Teachey, David T, Devidas, Meenakshi, Wood, Brent L, Chen, Zhiguo, Hayashi, Robert J, Hermiston, Michelle L, Annett, Robert D, Archer, J Hunter, Asselin, Barbara L, August, Keith J, Cho, Steve Y, Dunsmore, Kimberly P, Fisher, Brian T, Freedman, Jason L, Galardy, Paul J, Harker-Murray, Paul, Horton, Terzah M, Jaju, Alok I, Lam, Allison, Messinger, Yoav H, Miles, Rodney R, Okada, Maki, Patel, Samir I, Schafer, Eric S, Schechter, Tal, Singh, Neelam, Steele, Amii C, Sulis, Maria Luisa, Vargas, Sarah L, Winter, Stuart S, Wood, Charlotte, Zweidler-McKay, Patrick, Bollard, Catherine M, Loh, Mignon L, Hunger, Stephen P, Raetz, Elizabeth A

Volltext

Can congenital pulmonary airway malformation be distinguished from Type I pleuropulmonary blastoma based on clinical and radiological features? von Feinberg, Adina, Hall, Nigel J, Williams, Gretchen M, Schultz, Kris Ann P, Miniati, Doug, Hill, D. Ashley, Dehner, Louis P, Messinger, Yoav H, Langer, Jacob C

Volltext

Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry von Nelson, Alexander T., Harris, Anne K., Watson, Dave, Miniati, Doug, Finch, Mike, Kamihara, Junne, Mitchell, Sarah G., Wilson, David B., Gettinger, Katie, Rangaswami, Arun A., Campos, José M., Lederman, Sara, Feltis, Brad A., Vasta, Lauren M., Harney, Laura A., Stewart, Douglas R., Dehner, Louis P., Messinger, Yoav H., Hill, D. Ashley, Schultz, Kris Ann P.

Volltext

Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease von Messinger, Yoav H., Mendelsohn, Nancy J., Rhead, William, Dimmock, David, Hershkovitz, Eli, Champion, Michael, Jones, Simon A., Olson, Rebecca, White, Amy, Wells, Cara, Bali, Deeksha, Case, Laura E., Young, Sarah P., Rosenberg, Amy S., Kishnani, Priya S.

Volltext

Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/ DICER1 Registry von Schultz, Kris Ann P, Harris, Anne K, Nelson, Alexander T, Watson, Dave, Lucas, Jr, John T, Miniati, Doug, Stewart, Douglas R, Hagedorn, Kelly N, Mize, William, Kamihara, Junne, Mitchell, Sarah G, Wilson, David B, Gettinger, Katie, Rangaswami, Arun A, Harney, Laura A, Rodriguez Galindo, Carlos, Bisogno, Gianni, Dehner, Louis P, Hill, D Ashley, Messinger, Yoav H

Volltext

Expression of p53 is significantly associated with recurrence-free survival and overall survival in pleuropulmonary blastoma (PPB): a report from the International Pleuropulmonary... von González, Iván A., Mallinger, Paige, Watson, Dave, Harris, Anne K., Messinger, Yoav H., Schultz, Kris Ann P., Field, Amanda, Hill, D. Ashley, Dehner, Louis P.

Volltext

Langerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib von Messinger, Yoav H., Bostrom, Bruce C., Olson, Damon R., Gossai, Nathan P., Miller, Lane H., Richards, Michael K.

Volltext

Assessing the role of positron emission tomography and bone scintigraphy in imaging of pleuropulmonary blastoma (PPB): A report from the International PPB/ DICER1 Registry von Hagedorn, Kelly N., Nelson, Alexander T., Towbin, Alexander J., Frederickson, Nicole, Mallinger, Paige, Lucas, John T., Dehner, Louis P., Messinger, Yoav H., Shulkin, Barry L., Mize, William A., Schultz, Kris Ann P.

Volltext